Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies.


Journal

NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390

Informations de publication

Date de publication:
03 Apr 2024
Historique:
received: 19 07 2023
accepted: 13 03 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 3 4 2024
Statut: epublish

Résumé

Dementia with Lewy bodies (DLB) is a neurodegenerative condition often co-occurring with Alzheimer's disease (AD) pathology. Characterizing white matter tissue microstructure using Neurite Orientation Dispersion and Density Imaging (NODDI) may help elucidate the biological underpinnings of white matter injury in individuals with DLB. In this study, diffusion tensor imaging (DTI) and NODDI metrics were compared in 45 patients within the dementia with Lewy bodies spectrum (mild cognitive impairment with Lewy bodies (n = 13) and probable dementia with Lewy bodies (n = 32)) against 45 matched controls using conditional logistic models. We evaluated the associations of tau and amyloid-β with DTI and NODDI parameters and examined the correlations of AD-related white matter injury with Clinical Dementia Rating (CDR). Structural equation models (SEM) explored relationships among age, APOE ε4, amyloid-β, tau, and white matter injury. The DLB spectrum group exhibited widespread white matter abnormalities, including reduced fractional anisotropy, increased mean diffusivity, and decreased neurite density index. Tau was significantly associated with limbic and temporal white matter injury, which was, in turn, associated with worse CDR. SEM revealed that amyloid-β exerted indirect effects on white matter injury through tau. We observed widespread disruptions in white matter tracts in DLB that were not attributed to AD pathologies, likely due to α-synuclein-related injury. However, a fraction of the white matter injury could be attributed to AD pathology. Our findings underscore the impact of AD pathology on white matter integrity in DLB and highlight the utility of NODDI in elucidating the biological basis of white matter injury in DLB.

Identifiants

pubmed: 38570511
doi: 10.1038/s41531-024-00684-4
pii: 10.1038/s41531-024-00684-4
pmc: PMC10991290
doi:

Types de publication

Journal Article

Langues

eng

Pagination

76

Subventions

Organisme : NIA NIH HHS
ID : R01 AG041851
Pays : United States
Organisme : NCRR NIH HHS
ID : C06 RR018898
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056366
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG040042
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG058738
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097495
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG011378
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS100620
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Acta Neuropathol. 2015 May;129(5):729-48
pubmed: 25758940
Aging Brain. 2022 Jan 25;2:100030
pubmed: 36908893
Neuroimage. 2016 Nov 15;142:394-406
pubmed: 27523449
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Neurology. 2020 Apr 28;94(17):743-755
pubmed: 32241955
Neurobiol Aging. 2021 May;101:172-180
pubmed: 33631469
Neuroimage Clin. 2019;23:101823
pubmed: 31004914
Cereb Cortex. 2009 Mar;19(3):497-510
pubmed: 18632739
Neurology. 2013 Nov 5;81(19):1681-9
pubmed: 24107861
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Neuroimage. 2013 Jun;73:239-54
pubmed: 22846632
Hum Brain Mapp. 2018 Jul;39(7):3005-3017
pubmed: 29575324
J Alzheimers Dis. 2015;47(1):117-27
pubmed: 26402760
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Ann Clin Transl Neurol. 2017 Aug 15;4(9):663-679
pubmed: 28904988
Neurology. 2012 Aug 7;79(6):553-60
pubmed: 22843258
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Front Neurol. 2021 Jun 14;12:662855
pubmed: 34194382
J Comput Assist Tomogr. 1990 Jul-Aug;14(4):561-70
pubmed: 2370355
Alzheimers Res Ther. 2021 Mar 29;13(1):69
pubmed: 33781319
Neuroimage. 2009 Jun;46(2):486-99
pubmed: 19385016
J Alzheimers Dis Parkinsonism. 2018;8(4):
pubmed: 30473927
Brain. 2018 Dec 1;141(12):3415-3427
pubmed: 30403785
Lancet Neurol. 2021 Mar;20(3):203-212
pubmed: 33609478
J Clin Sleep Med. 2013 May 15;9(5):475-80
pubmed: 23674939
Brain. 2019 Oct 1;142(10):3230-3242
pubmed: 31501889
Front Neurosci. 2017 Sep 04;11:451
pubmed: 28928628
Alzheimers Dement (Amst). 2018 Sep 17;10:678-687
pubmed: 30426064
Science. 2002 Jul 19;297(5580):353-6
pubmed: 12130773
Neurobiol Aging. 2015 Jan;36(1):452-61
pubmed: 25128280
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Neurology. 2004 Jan 27;62(2):181-7
pubmed: 14745051
Neuroimage. 2015 Jan 15;105:32-44
pubmed: 25462697
Ann Neurol. 2017 Jan;81(1):58-67
pubmed: 27863444
Mov Disord. 2022 Jun;37(6):1256-1264
pubmed: 35261094
Neuroimage Clin. 2020;27:102333
pubmed: 32674011
Neurobiol Aging. 2021 May;101:187-198
pubmed: 33631470
Alzheimers Res Ther. 2010 Aug 31;2(4):23
pubmed: 20807454
Alzheimers Dement (Amst). 2021 Apr 01;13(1):e12124
pubmed: 33816751
Mol Neurodegener. 2023 Jun 28;18(1):42
pubmed: 37381015
Neuroimage Clin. 2014 Feb 19;4:604-14
pubmed: 24936411
Neurology. 2023 Jul 11;101(2):e178-e188
pubmed: 37202168
Brain. 2016 Oct;139(Pt 10):2740-2750
pubmed: 27452602
Neurology. 2018 Jul 24;91(4):e313-e318
pubmed: 29959265
Neurology. 2023 Feb 21;100(8):e846-e859
pubmed: 36443011
Parkinsonism Relat Disord. 2023 Feb;107:105285
pubmed: 36682958
Alzheimers Dement. 2018 Mar;14(3):330-339
pubmed: 29100980
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Alzheimers Res Ther. 2014 Apr 09;6(2):18
pubmed: 25031634
Mov Disord. 2013 Feb;28(2):169-75
pubmed: 23225334
JAMA Netw Open. 2019 Dec 2;2(12):e1916439
pubmed: 31790563
Neuroimage. 2012 Jul 16;61(4):1000-16
pubmed: 22484410
Neurobiol Aging. 2017 Aug;56:172-179
pubmed: 28552181
Lancet Neurol. 2017 Jan;16(1):55-65
pubmed: 27979356
Neurobiol Aging. 2015 Jun;36(6):2010-7
pubmed: 25863527
Magn Reson Imaging. 2009 Oct;27(8):1163-74
pubmed: 19249168
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Magn Reson Med. 2013 Jun;69(6):1534-40
pubmed: 23625329
Neuroimage Clin. 2014 Apr 21;4:730-42
pubmed: 24936424
Neurology. 2023 May 30;100(22):e2269-e2278
pubmed: 37068958
Magn Reson Med. 2016 Nov;76(5):1574-1581
pubmed: 26745823
Neurology. 2007 Jan 2;68(1):13-9
pubmed: 17200485
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):7813-7818
pubmed: 29991596
Neuroimage. 2016 Jan 15;125:1063-1078
pubmed: 26481672
Neurology. 2010 Jun 1;74(22):1814-21
pubmed: 20513818
Neurology. 2012 Aug 28;79(9):906-14
pubmed: 22895591
Neurobiol Aging. 2019 Jan;73:74-81
pubmed: 30339962
J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):745-750
pubmed: 33563809
Brain. 2021 Nov 29;144(10):3212-3225
pubmed: 34114602
Brain Commun. 2021 May 19;3(2):fcab106
pubmed: 34136811

Auteurs

Elijah Mak (E)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Department of Psychiatry, University of Cambridge, Cambridge, UK.

Robert I Reid (RI)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Department of Information Technology, Mayo Clinic, Rochester, MN, USA.

Scott A Przybelski (SA)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Timothy G Lesnick (TG)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Christopher G Schwarz (CG)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Matthew L Senjem (ML)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Department of Information Technology, Mayo Clinic, Rochester, MN, USA.

Sheelakumari Raghavan (S)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Prashanthi Vemuri (P)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Clifford R Jack (CR)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Hoon Ki Min (HK)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Manoj K Jain (MK)

Department of Radiology, Mayo Clinic, Jacksonville, FL, USA.

Toji Miyagawa (T)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Leah K Forsberg (LK)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Julie A Fields (JA)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Rodolfo Savica (R)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Jonathan Graff-Radford (J)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

David T Jones (DT)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Hugo Botha (H)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Erik K St Louis (EK)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Vijay K Ramanan (VK)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Dennis W Dickson (DW)

Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.

Neill R Graff-Radford (NR)

Laboratory of Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA.

Tanis J Ferman (TJ)

Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.

Ronald C Petersen (RC)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Val J Lowe (VJ)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Bradley F Boeve (BF)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

John T O'Brien (JT)

Department of Psychiatry, University of Cambridge, Cambridge, UK.

Kejal Kantarci (K)

Department of Radiology, Mayo Clinic, Rochester, MN, USA. kejal.kantarci@mayo.edu.

Classifications MeSH